Table 3 Prevalence of the examined mutations/polymorphisms among PsV cases and healthy controls

2 / 507 0,39%

1) / 510 0,20%

0,5597

2,016

1 / 507 0,20%

0

0,3156

3,024

22 (+) / 503 4,37%

28 (+) / 507 5,52%

0,4000

0,7824

2 (+) / 503 0,40%

2 (+) / 507 0,39%

0,9937

1,008

43 (+) / 500 8,60%

41 (+) / 510 8,04%

0,7469

1,076

200 / 491 40,73%

199 / 493 40,37%

0,9064

1,015

127 / 491 25,87%

114 / 493 23,12%

0,3173

1,160

240 / 503 47,71%

240 / 510 47,06%

0,8347

1,027

82 / 503 16,30%

89 / 510 17,45%

0,6255

0,9213

33 / 428 7,71%

35 / 501 6,99%

0,6727

1,112

0 / 428 0%

2 / 501 0,40%

0,1907

0,2331

50 / 448 11,16%

63 / 510 12,35%

0,5681

0,8914

1 / 448 0,22%

6 / 510 1,18%

0,0839

0,1879

30 / 435 6,90%

37 / 501 7,38%

0,7724

0,9289

1 / 435 0,23%

2 / 501 0,40%

0,6476

0,5749

240 / 490 48,98%

252 / 508 49,61%

0,8431

0,9752

99 / 490 20,20%

99 / 508 19,49%

0,7768

1,046

26 (+) / 501 5,19%

28 (+) / 511 5,48%

0,8375

0,9442

192 / 503 38,17%

195 / 512 38,09%

0,9778

1,004

34 / 503 6,76%

33 / 512 6,44%

0,8403

1,052

261 / 501 52,10%

234 / 509 45,97%

0,0516

1,278

119 / 501 23,75%

123 / 509 24,17%

0,8779

0,9776

0 (+) / 499 0%

0 (+) / 508 0%

-

-

223 / 488 45,70%

227 / 499 45,49%

0,9483

1,008

47 / 488 9,63%

44 / 499 8,82%

0,6587

1,102